Boehringer Ingelheim and Eli Lilly to modernise present collaboration

Vifor Pharma announces commercial partnership with Janssen for new diabetic kidney disease treatment

Masters Speciality Pharma unveils Neuropad in Brazil for detection of diabetic foot syndrome

Microbion's lead antimicrobial given generic name Pravibismane

JAMA Oncology Publishes Analysis of Patients with Prior Gastrectomy Treated with Lonsurf

FDA approves new first triple combination therapy Trikafta (elexacaftor/ivacaftor/tezacaftor) for cystic fibrosis

Aerie Pharmaceuticals Names Davis as Chief Compliance Officer

Perspectum announces chronic liver screening partnership with Precious Medical Centre

Goldfinch Bio Inks Licensing Agreement with Takeda for CB1 Monoclonal Antibody for the Treatment of Rare and Metabolic Kidney Diseases

Senseonics awards equity grants to 16 new employees under inducement plan

NKF announces US FDA approval for INVOKANA to reduce kidney disease and cardiovascular events in patients with Type 2 diabetes

Imbed Awarded USD 1.5m NIH Grant to Fight Biofilms in Wounds

Imbed wins USD1.5m NIH grant to develop bioresorbable biofilms wound dressing

Zealand Pharma reports positive results in paediatric Phase 3 trial with dasiglucagon for severe hypoglycaemia

Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th annual meeting of the European Association for the Study of Diabetes